Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  ISIS Pharmaceuticals, Inc.    ISIS   US4643301090

Delayed Quote. Delayed Nasdaq - 09/02 02:39:41 pm
40.5 USD   -0.64%
6h ago ISIS PHARMACEUTICALS : Drugs from Isis' Lipid Franchise Highlighted at Euro..
4d ago ISIS PHARMACEUTICALS : ISIS) Jumps 5.21% on August 25
5d ago ISIS PHARMACEUTICALS : Assigned Patent
 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/26/2014 08/27/2014 08/28/2014 08/29/2014 09/02/2014 Date
40.01(c) 39.58(c) 39.9(c) 40.76(c) 40.5 Last
4 942 426 3 200 062 3 274 317 2 019 315 1 507 733 Volume
+10.77% -1.07% +0.81% +2.16% -0.64% Change
More quotes
Company
Isis Pharmaceuticals, Inc. engages in the development and commercialization of drugs to treat various health conditions, including inflammatory, viral, metabolic and cardiovascular and dermatological diseases and cancer. The company operates in two segments: Drug Discovery & Development and Regulus. 
Sector
Biotechnology & Medical Research
Calendar
09/08 | 12:50pmPresentation
Surperformance© rating of ISIS Pharmaceuticals, Inc.
Trading Rating : Investor Rating :
More about the company
Chart ISIS PHARMACEUTICALS, INC.
Duration : Period :
ISIS Pharmaceuticals, Inc. Technical Analysis Chart | ISIS | US4643301090 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 180 M
EBIT 2014 -73,4 M
Net income 2014 -87,0 M
Finance 2014 21,5 M
Yield 2014 -
Sales 2015 163 M
EBIT 2015 -108 M
Net income 2015 -135 M
Finance 2015 213 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 26,6x
EV / Sales 2015 28,1x
Capitalization 4 799 M
More Financials
Latest news on ISIS PHARMACEUTICALS, INC.
6h ago ISIS PHARMACEUTICALS : Drugs from Isis' Lipid Franchise Highlighted at European ..
4d ago ISIS PHARMACEUTICALS : ISIS) Jumps 5.21% on August 25
5d ago ISIS PHARMACEUTICALS : Assigned Patent
5d ago ISIS PHARMACEUTICALS : Initiates Phase 3 Study of ISIS-APOCIII Rx in Patients wi..
6d ago ISIS PHARMACEUTICALS : ISIS) Jumps 10.77% on August 26
08/21 ISIS PHARMACEUTICALS : Other Events (form 8-K)
08/15 ISIS PHARMACEUTICALS : Earns $2M from the Advancement of ISIS-SMN Rx in Children..
08/14 ISIS PHARMACEUTICALS : Expert Briefing on Biotech Stocks -- Nanosphere, Vanda Ph..
08/06 ISIS PHARMACEUTICALS : Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Sp..
08/06 ISIS PHARMACEUTICALS : Recent Findings from ISIS Provide New Insights into Vascu..
08/04 ISIS PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITI..
08/04 ISIS PHARMACEUTICALS : Reports Financial Results and Highlights for Second Quart..
More news
4-Traders Strategies on ISIS PHARMACEUTICALS, INC. 
08/14A resistance as obstacle
More Strategies
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
ISIS Pharmaceuticals, Inc. : Income Statement Evolution
More Financials
EPS Revisions
ISIS Pharmaceuticals, Inc. : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF